Vireo Growth Inc. VREOF

 — 
11.26 (0.22) (1.92%) as of 25 Sep
Market cap
—
P/E
0.0×
Growth Flags show if company had growth for consecutive years

Insider Decisions

in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership —

Capital & Financial Ratios

Market Cap —
Revenue 511.67
Net Income (67.11)
Free Cash Flow (118.11)
Net Debt 207.50
Current Ratio 1.01
Debt/Equity 0.75
P/E ratio 0.00
P/S ratio 0.99
P/B ratio 1.14
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next 5Y EPS Growth —
in millions of $

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 16 92 124 124
Receivables 15 17 37 84
Inventory 19 22 60 149
Other 93 99 2 22
149 230 305 395
2023 2024 2025 Q'26
Payables 8 10 50 125
ST’ Debt 60 1 18 43
Other 88 89 0 37
179 135 192 391
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — 53.28%
Cash Flow — — 0.00%
Earnings — — 0.00%
Book Value — — 347.05%

Revenue

Mar Jun Sep Dec Year
’26 106 209 — — —
’25 25 48 92 105 269
’24 24 25 25 25 99
’23 19 20 25 24 88
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 12 2 — — —
’25 (3) (5) (7) 19 4
’24 (1) 0 (3) (6) (10)
’23 (4) 2 2 0 (1)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 1 (106) — — —
’25 (4) (9) (21) 8 (26)
’24 (2) (3) (7) (9) (22)
’23 (4) (1) 1 (3) (7)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (0.60) 0.00 — — —
’25 (0.60) (0.90) (0.83) (0.60) (2.70)
’24 (1.41) (0.14) (0.60) (2.10) (4.80)
’23 (1.97) (1.72) (1.11) (0.87) (5.67)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — 23.22 6.00 36.00 4.17 2.70 6.36 9.24

Analyst estimates 2026–2028

Powerpack
Low Price
— — — 151.89 47.70 115.20 79.50 9.00 20.85 24.00
High Price
— — — — — — — 490 520 612
Employees
— — — — — — 0 0 0 0
Revenue/Emp
— — — — — — 75 88 99 269
Revenue
— — — — — — 41.42% 50.04% 51.09% 47.29%
Gross Margin
— — — — — — (37) (18) (17) (40)
EBT
— — — — — — (49.00%) (20.22%) (17.00%) (14.85%)
EBT Margin
— — — — — — (42) (26) (28) (68)
Net Income
— — — — — — 4 4 3 22
Depreciation
— — — — — — 17.49 19.57 16.54 10.99
Revenue/Sh
— — — — — — (9.95) (5.67) (4.80) (2.70)
Earnings/Sh
— — — — — — (4.24) (0.21) (1.70) 0.15
Cash Flow/Sh
— — — — — — (1.25) (1.29) (1.95) (1.22)
Capex/Sh
— — — — — — (5.48) (1.50) (3.65) (1.07)
Free CF/Sh
— — — — — — 0.81 (3.56) 9.25 12.57
Book Value/Sh
— — — — — — 4 5 6 24
Shares
— — — — — — 0.00 0.00 0.00 0.00
PE Ratio
— — — — — — 0.29 0.36 1.02 1.67
PS Ratio
— — — — — — 6.32 0.00 1.82 1.46
PB Ratio
— — — — — — 0.87 0.97 0.82 2.14
EV/Sales
— — — — — — (2.73) (15.05) (3.72) (22.07)
EV/FCF
— — — — — — (18) (1) (10) 4
Op' Cash Flow
— — — — — — (5) (6) (12) (30)
Capex
— — — — — — (23) (7) (22) (26)
FCF
— — — — — — 17 (31) 95 114
Working Cap'
— — — — — — 58 69 72 154
Total Debt
— — — — — — 43 53 (19) 30
Net Debt
— — — — — — 3 (16) 56 307
Sh' Equity
— — — — — — 0.00% (14.92%) (12.12%) (12.43%)
ROA
— — — — — — (9.36%) 17.70% 23.44% (0.19%)
ROIC
— — — — — — 0.00% 405.42% (141.74%) (37.53%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Vireo Growth Inc. (VREOF) Latest News

News by impact score

Fine-tune

21 Aug

4

Vireo Growth Inc. has completed the acquisition of C21 Investments Inc. Acquisition of C21 Investments constitutes a major strategic expansion altering Vireo Growth's scale and positioning.

13 Aug

3

Vireo Growth Inc. (VREOF) launches a share buyback program. Buyback program supports share price and signals management confidence.

12 Aug

4

Vireo Growth Inc. achieves strong revenue growth supporting a $45.00 price target for VREOF shares. Strong revenue growth and $45 price target point to major positive shifts in performance and market perception.

4

Vireo Growth Inc. demonstrates strong revenue growth that backs a $45.00 price target for VREOF shares. Strong revenue growth combined with a high price target signals major positive effects on company trajectory and investor outlook.

11 Aug

4 transcript

Vireo Growth Inc reported Q2 2026 revenue of $209 with a 335% year-over-year increase. A 335% revenue surge signals major expansion that can materially shift financial trajectory and investor views.

3

Vireo Growth Inc. reported its second quarter 2026 financial results. Quarterly results typically influence short-term stock movement and sentiment without guaranteeing major long-term shifts.

7 Aug

4

C21 shareholders approve arrangement with Vireo Growth Inc. Shareholder approval advances a strategic arrangement likely to alter Vireo Growth Inc.'s corporate structure and market trajectory.

4

Vireo Growth Inc. receives regulatory approval and completes acquisition of PharmaCann Colorado retail assets. Acquisition expands Vireo Growth retail footprint in Colorado after regulatory clearance.

3

Vireo Growth Inc. announces an asset-based credit facility. Asset-based credit facility supplies Vireo Growth with new capital access that supports operations without fundamentally shifting long-term trajectory.

31 Jul

4

Vireo Growth Inc. announces a four-deal transaction to establish presence in Ohio. Four-deal transaction to enter Ohio market represents major strategic expansion likely to drive growth and alter competitive position.

28 Jul

4

FLUENT shareholders approve all-stock transaction with Vireo Growth Inc. All-stock transaction approval advances Vireo Growth's integration into larger entity and alters its independent trajectory.

27 Jul

4

Vireo Growth Inc. will acquire Planet 13 Holdings in an all-stock deal. All-stock acquisition of Planet 13 marks major strategic expansion for Vireo Growth.

4

Vireo Growth Inc. acquires Planet 13 Holdings Inc. Acquisition of Planet 13 Holdings Inc. delivers major strategic expansion and shifts Vireo Growth Inc. trajectory.

23 Jul

3

FLUENT, operating under Vireo Growth Inc., signed a definitive agreement to sell its New York license and certain operations. Divestiture of New York license and operations will likely adjust revenue streams and market presence without fully redefining overall trajectory.

20 Jul

4

Vireo Growth Inc. (VREOF) will acquire up to $35 million in assets from Cannabist. Acquisition of up to 35 million dollars in assets expands Vireo Growth operations and market position substantially.

4

Vireo Growth Inc. acquires certain assets of The Cannabist Company Holdings Inc. Asset acquisition represents major strategic expansion that alters Vireo Growth's market position and growth trajectory.

17 Jul

4

FLUENT issues update and supplemental disclosure on circular for shareholder approval of all-stock transaction with Vireo Growth Inc. All-stock transaction approval with FLUENT marks major strategic move that can significantly shift Vireo Growth trajectory and investor sentiment.

3

Vireo Growth Inc. completed acquisition of a Pennsylvania dispensary license. Pennsylvania dispensary license acquisition expands Vireo Growth Inc. operational reach in a new market.

2 Jul

4

Vireo Growth Inc. completed a transaction acquiring a Pennsylvania dispensary license, expanding operations into its eleventh state. Entry into Pennsylvania adds a major new market and revenue stream that can materially shift company trajectory.

18 Jun

4

Vireo Growth Inc. completes acquisition of equity interest in Maryland dispensaries. Acquisition expands Vireo Growth Inc. market presence and operations in cannabis sector.

15 Jun

4

Vireo Growth Inc. and C21 Investments Inc. announced a definitive arrangement agreement. Definitive arrangement agreement marks major strategic move that can significantly shift Vireo Growth Inc. operations and market trajectory.

9 Jun

4

Vireo Growth Inc. acquires Bridgewell Agribusiness, with D.A. Davidson acting as exclusive advisor to Bridgewell in the transaction. Acquisition expands Vireo Growth's agribusiness operations and competitive positioning in a material way.

5 Jun

4

Vireo Growth Inc. completed acquisition of Bridgewell Agribusiness LLC and announced plans to acquire dispensaries in Nevada and Maryland. Acquisitions expand operations into new states and add assets that alter company trajectory.

25 May

4

Vireo Growth Inc. announced it will acquire Bridgewell Agribusiness LLC. Acquisition marks a major strategic expansion that can significantly shift Vireo Growth's operations and market position.

4

Vireo Growth Inc. acquires Bridgewell Agribusiness LLC. Acquisition of Bridgewell Agribusiness LLC expands Vireo Growth Inc. operations and market reach.

14 May

3

Vireo Growth Inc. achieves strong revenue growth that supports a $1.50 price target for VREOF shares. Revenue growth directly enhances Vireo Growth's market valuation and attracts investor interest.

12 May

4 transcript

Vireo Growth Inc (VREOF) highlighted strategic acquisitions during its Q1 2026 earnings call as key growth drivers. Strategic acquisitions position Vireo Growth Inc for major trajectory shifts via expanded operations and market reach.

4

Vireo Growth Inc. (VREOF) released its financial results for the first quarter of 2026. Quarterly results directly shape investor views and near-term stock movement for Vireo Growth Inc.

30 Apr

4

Vireo Growth Inc. (VREOF) acquires FLUENT in an all-stock transaction. All-stock acquisition of FLUENT marks major strategic expansion altering Vireo Growth operations and market position.

4

Vireo Growth Inc. acquires FLUENT in an all-stock transaction. All-stock acquisition of FLUENT marks a major strategic expansion altering Vireo Growth's market position.

stockrow.com/VREOF · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com